These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 697920)

  • 1. Effects of single doses of tranylcypromine on platelet MAO and amine uptake in normal subjects.
    Gentil V; Alevizos B; Lader M
    Biochem Pharmacol; 1978; 27(8):1197-201. PubMed ID: 697920
    [No Abstract]   [Full Text] [Related]  

  • 2. Tranylcypromine lowers human platelet MAO B activity but not concentration.
    Fritz RR; Malek-Ahmadi P; Rose RM; Denney RM; Abell CW
    Biol Psychiatry; 1983 Jun; 18(6):685-94. PubMed ID: 6871302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of drugs on human blood platelet and plasma amine oxidase activity in vitro and in vivo.
    Robinson DS; Lovenberg W; Keiser H; Sjoerdsma A
    Biochem Pharmacol; 1968 Jan; 17(1):109-19. PubMed ID: 4384242
    [No Abstract]   [Full Text] [Related]  

  • 4. Tranylcypromine and inhibition of MAO activity.
    Bowden CL
    J Clin Psychopharmacol; 1984 Jun; 4(3):172-3. PubMed ID: 6736280
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of caroxazone, a new antidepressant drug, on monoamine oxidases in healthy volunteers.
    Moretti A; Caccia C; Martini A; Bonollo L; Amico A; Sega R; Nicolella V; Nicolis FB
    Br J Clin Pharmacol; 1981 May; 11(5):511-5. PubMed ID: 7272163
    [No Abstract]   [Full Text] [Related]  

  • 6. Platelet monoamine oxidase inhibition by deprenyl and tranylcypromine: implications for clinical use.
    Simpson GM; Frederickson E; Palmer R; Pi E; Sloane RB; White K
    Biol Psychiatry; 1985 Jun; 20(6):684-7. PubMed ID: 3922441
    [No Abstract]   [Full Text] [Related]  

  • 7. Reduced monoamine oxidase activity in blood platelets from schizophrenic patients.
    Murphy DL; Wyatt RJ
    Nature; 1972 Jul; 238(5361):225-6. PubMed ID: 4558353
    [No Abstract]   [Full Text] [Related]  

  • 8. Tranylcypromine ('Parnate') overdose: measurement of tranylcypromine concentrations and MAO inhibitory activity and identification of amphetamines in plasma.
    Youdim MB; Aronson JK; Blau K; Green AR; Grahame-Smith DG
    Psychol Med; 1979 May; 9(2):377-82. PubMed ID: 472083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MAO inhibitors and platelet MAO inhibition.
    Giller E; Lieb J
    Commun Psychopharmacol; 1980; 4(1):79-82. PubMed ID: 7398245
    [No Abstract]   [Full Text] [Related]  

  • 10. Binding of the imidazoline ligand 3H-2-benzofuranyl-2-imidazoline (BFI) to human brain and platelets. Potentiation by tranylcypromine and role of MAO isoforms.
    Steinberg MI; Wiest SA; Pickard RT; Chen K; Shih JC
    Ann N Y Acad Sci; 1999 Jun; 881():193-8. PubMed ID: 10415915
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibition of platelet monoamine oxidase in depressed subjects treated with phenelzine.
    Davidson J; McLeod MN; White HL
    Am J Psychiatry; 1978 Apr; 135(4):470-2. PubMed ID: 345826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of cannabinoids on the activity of monoamine oxidase in normal human platelets.
    Mazor M; Dvilansky A; Aharon M; Lazarovitz Z; Nathan I
    Arch Int Physiol Biochim; 1982 Apr; 90(1):15-20. PubMed ID: 6179486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of adrenaline injections on human platelet monoamine oxidase and related measures.
    Gentil V; McCurdy RL; Alevizos B; Lader MH
    Psychopharmacology (Berl); 1976 Nov; 50(2):187-92. PubMed ID: 826960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet monoamine oxidase and plasma amine oxidase: effect of anticoagulant and centrifugation technique on platelet yield and enzyme activity.
    Baron M; Levitt M; Gruen R
    Neuropsychobiology; 1983; 9(1):9-12. PubMed ID: 6412154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interference by endogenous amines in the determination of monoamine oxidase activity of human platelet samples.
    Narasimhachari N
    Res Commun Chem Pathol Pharmacol; 1979 Jul; 25(1):143-51. PubMed ID: 451349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-dose effects of tranylcypromine on psychophysiological measures in normals.
    Gentil V; Alevizos B; Felix-Gentil M; Lader M
    Br J Clin Pharmacol; 1978 Jun; 5(6):536-8. PubMed ID: 350253
    [No Abstract]   [Full Text] [Related]  

  • 17. Insights into the mechanisms of action of the MAO inhibitors phenelzine and tranylcypromine: a review.
    Baker GB; Coutts RT; McKenna KF; Sherry-McKenna RL
    J Psychiatry Neurosci; 1992 Nov; 17(5):206-14. PubMed ID: 1362653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetic constants of platelet monoamine oxidase in schizophrenia.
    Jackman HL; Meltzer HY
    Am J Psychiatry; 1983 Aug; 140(8):1044-7. PubMed ID: 6869590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet mono-amine oxidase activity in the human fetus.
    Jones JB; Southgate J
    Dev Med Child Neurol; 1976 Oct; 18(5):640-2. PubMed ID: 976617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Activity of the enzymes participating in the metabolism of biogenic amines in patients with depressive syndromes. I. Platelet monoamine oxidase (MAO) activity].
    Matsumoto H; Pietruszewska I; Roguska E
    Psychiatr Pol; 1983; 17(1):7-11. PubMed ID: 6622594
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.